Header01-REBRAND_MENARINISILICONBIOSYSTEMS

 

Press Releases

11/30/2021

New CELLSEARCH® Circulating Multiple Myeloma Test now available to help community physicians optimize patient care


As the market leader in cell-based liquid biopsies, Menarini Silicon Biosystems is offering community hematology-oncologists an opportunity to have patient blood samples sent to a US centralized laboratory where its CELLSEARCH® technology can enumerate Circulating Multiple Myeloma Cells (CMMCs) for non-invasive monitoring of disease

continue →

Topics: CELLSEARCH, Liquid biopsy, Multiple myeloma, CLIA Lab, LDT

02/16/2021

Menarini Silicon Biosystems announces launch of CellMag™ product line offering affordable Gold Standard Circulating Tumor Cells capture


CELLMAG – a cost effective, manual and simple approach for the enrichment and staining of extremely rare cells from blood

continue →

Topics: CTCs, CELLSEARCH, Liquid biopsy, Blood Enrichment, CellMag

02/28/2020

Menarini Silicon Biosystems to Announce New Solutions for Advancing Liquid Biopsy

Developments for CELLSEARCH and DEPArray Technologies to be Featured at the Molecular Medicine Tri-Conference

continue →

Topics: Liquid biopsy, Precision Medicine, Circulating tumor cells, rare cells

12/10/2019

New Menarini CELLSEARCH Studies to be Presented at San Antonio Breast Cancer Symposium

Northwestern University researchers use gold standard  liquid-biopsy technology to deepen understanding of metastatic breast cancer

continue →

Topics: Liquid biopsy, Precision Medicine, Circulating tumor cells, metastatic breast cancer, rare cells

10/31/2019

Menarini Silicon Biosystems to Debut VRNxT Technology at 25th Annual Meeting of the Association for Molecular Pathology

Automated volume reduction instrument increases precision and accuracy in rare cell workflows

continue →

Topics: Liquid biopsy, Precision Medicine, rare cells, volume reduction, VRNxT

09/23/2019

Menarini Silicon Biosystems to Host ESMO Symposium on Clinical Importance of Circulating Tumor Cells

World-renowned faculty will present current evidence and potential clinical applications of CTCs for advanced breast and prostate cancer

continue →

Topics: CTCs, Liquid biopsy, Precision Medicine, rare cells

05/30/2019

CellSearch Studies at ASCO Show Potential Predictive Role for Circulating Tumor Cells in Metastatic Breast Cancer

Liquid biopsy data reveals “intriguing” association between ESR1 mutations, HER2 alterations and prognosis

continue →

Topics: CELLSEARCH, Liquid biopsy, Precision Medicine, metastatic breast cancer

03/27/2019

New CellSearch Data To Be Presented at AACR Deepens Understanding of Metastatic Breast Cancer

Northwestern Researchers Use Gold-Standard Liquid Biopsy Technology to Identify Potential New Biomarker

continue →

Topics: deparray, CELLSEARCH, Liquid biopsy, Precision Medicine, metastatic breast cancer, lynphoma, CTC cluster, melanoma

03/12/2019

Menarini Silicon Biosystems Develops New Assay Workflow for Circulating Multiple Myeloma Cells

Technology to Be Introduced at the Molecular Medicine Tri-Conference May Offer Alternative to Invasive Bone Marrow Biopsy for Monitoring Disease Progression

continue →

Topics: FFPE, deparray, CELLSEARCH, Liquid biopsy, Precision Medicine, Multiple myeloma, CMMCs

11/29/2018

New Studies Using CELLSEARCH Circulating Tumor Cell Test to be Featured at San Antonio Breast Cancer Symposium

Research Adds to Growing Evidence of Clinical Utility of CTCs for the management of Metastatic Breast Cancer Patients

continue →

Topics: CTCs, CELLSEARCH, Liquid biopsy, Precision Medicine, metastatic breast cancer